Johnson & Johnson and the National Academy of Medicine have collaborated on a competition to kick-start research that's poised to revolutionize the field of healthy longevity. Meet some of the researchers who have big ideas in the pursuit of "immorbidity."
In addition to its own cadre of scientists hard at work fighting the pandemic, Johnson & Johnson also supports external researchers and entrepreneurs equally dedicated to finding solutions for the current health crisis. We take a look at some of this groundbreaking work happening across the globe—from San Francisco to Seoul.
The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.
They both had stressful experiences as new parents and took those challenging moments and turned them into something positive—inventions that have the potential to help other parents and newborns thrive, especially during the current pandemic.
Brilliant, outside-the-box ideas to help people live without illness as they live longer. That's what Johnson & Johnson and the National Academy of Medicine are looking for through a unique collaboration—and they’re putting up millions of dollars in prize money to find them.
Siddhartha Mukherjee, M.D., made his name as an oncologist, researcher and Pulitzer Prize-winning writer. Now he's the scientific adviser of an immuno-oncology start-up that's tackling a rare form of leukemia. In an exclusive interview, he reveals his vision for the future of cancer treatments.
Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson's venture capital division, which invests in dozens of companies each year. He shares what's on his radar for 2019.
At just 27 years old, Jessica Traver is leading the charge at IntuiTap, a company that wants to reinvent how spinal taps are performed. She reflects on the successes—and setbacks—she's had as a game-changing entrepreneur.
Artificial intelligence. Smart health tech devices. Mobile wellness management. This is the future of healthcare—and Johnson & Johnson's new innovation hub in Manhattan is poised to bring medicine and technology together in once unimaginable ways.
It's been six months since we last checked in with IntuiTap Medical CEO Jessica Traver, an incubatee at JLABS @ TMC. She shares with us the highs and, yes, lows of her journey to build a budding medical device company.